30.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$30.87
Offen:
$30.93
24-Stunden-Volumen:
2.72M
Relative Volume:
0.62
Marktkapitalisierung:
$15.69B
Einnahmen:
$11.89B
Nettoeinkommen (Verlust:
$-560.00M
KGV:
-27.80
EPS:
-1.1
Netto-Cashflow:
$191.00M
1W Leistung:
+0.49%
1M Leistung:
+0.16%
6M Leistung:
-8.20%
1J Leistung:
-9.66%
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BAX
Baxter International Inc
|
30.58 | 15.62B | 11.89B | -560.00M | 191.00M | -1.10 |
![]()
ISRG
Intuitive Surgical Inc
|
552.41 | 196.08B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
173.01 | 49.62B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
85.38 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
244.76 | 36.04B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
80.12 | 15.87B | 3.93B | 415.40M | 384.70M | 2.06 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-26 | Fortgesetzt | Goldman | Buy |
2025-02-24 | Hochstufung | Argus | Hold → Buy |
2025-02-20 | Fortgesetzt | Barclays | Overweight |
2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2024-05-30 | Eingeleitet | Goldman | Neutral |
2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2023-03-29 | Eingeleitet | UBS | Neutral |
2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
2022-10-18 | Eingeleitet | Barclays | Overweight |
2022-10-12 | Eingeleitet | Jefferies | Hold |
2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
2022-02-18 | Bestätigt | Raymond James | Outperform |
2022-02-18 | Bestätigt | Stifel | Buy |
2022-02-18 | Bestätigt | UBS | Neutral |
2022-02-18 | Bestätigt | Wells Fargo | Overweight |
2022-02-11 | Eingeleitet | Goldman | Neutral |
2022-01-07 | Fortgesetzt | Citigroup | Buy |
2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
2021-05-25 | Eingeleitet | Barclays | Equal Weight |
2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-01-06 | Herabstufung | UBS | Buy → Neutral |
2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
2020-09-04 | Herabstufung | Argus | Buy → Hold |
2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
2020-03-19 | Hochstufung | Stifel | Hold → Buy |
2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-05 | Eingeleitet | Citigroup | Neutral |
2020-02-13 | Eingeleitet | Goldman | Buy |
2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
2018-11-02 | Hochstufung | Argus | Hold → Buy |
2018-10-16 | Eingeleitet | Barclays | Underweight |
2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
2018-02-06 | Bestätigt | Citigroup | Neutral |
2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 | BAX Stock News - GuruFocus
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 - FinancialContent
GF Fund Management CO. LTD. Takes Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Do These 3 Checks Before Buying Baxter International Inc. (NYSE:BAX) For Its Upcoming Dividend - simplywall.st
We Wouldn't Be Too Quick To Buy Baxter International Inc. (NYSE:BAX) Before It Goes Ex-Dividend - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Raiffeisen Bank International AG Purchases Shares of 76,587 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter launches room-temperature collagen sealing pad - MassDevice
Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS) - PR Newswire
Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & SuppliesDiversified Stocks - Yahoo Finance
Parkwood LLC Invests $10.75 Million in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of “Hold” from Analysts - Defense World
Baxter’s Q4 Performance Beats Expectations - Medical Product Outsourcing
Baxter at Bank of America 2025 Healthcare Conference: Strategic Shifts and Growth - Investing.com Nigeria
Becton Dickinson Sues Baxter Over Infusion Pump Patents - Law360
BD files patent infringement lawsuit against Baxter over infusion pump tech - Drug Delivery Business
Becton Dickinson Says Baxter Infringes Infusion-Pump Patents - Bloomberg Law News
Transcript : Baxter International Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Hurricane Helene Updates - Baxter
Ameriprise Financial Inc. Sells 2,346,164 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Morgan Stanley Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter International Inc. (BAX) Announces Results of 2025 Annual Meeting - GuruFocus
Baxter International Holds 2025 Annual Meeting with Key Decisions - TipRanks
Baxter International Inc (BAX) Shares Up 4.23% on May 8 - GuruFocus
The 'Goldilocks' Case For Baxter International (NYSE:BAX) - Seeking Alpha
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Baxter International First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Beyond the Balance Sheet: What SWOT Reveals About Baxter Interna - GuruFocus
Baxter International IncDeclares Quarterly Dividend Of $0.17 Per Share - marketscreener.com
Baxter Declares Quarterly Dividend | BAX Stock News - GuruFocus
Baxter Declares Quarterly Dividend - Bluefield Daily Telegraph
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
What Are Wall Street Analysts' Target Price For Baxter International Stock? - Barchart.com
What Are Wall Street Analysts' Target Price for Baxter International Stock? - inkl
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail
Wells Fargo & Company Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - Defense World
Baxter stock rises on earnings beat, guidance raise - MSN
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Call Transcript - Insider Monkey
Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica
Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Baxter Intl (BAX): Wells Fargo Lowers Price Target to $33 | BAX Stock News - GuruFocus
Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus
Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com
Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com
JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ... - Yahoo
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS Surpass Expectations - GuruFocus
Baxter International Reports Strong Q1 2025 Results - TipRanks
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):